We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Physical Activity and Inactivity in Lung Cancer Survivors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00582348
Recruitment Status : Active, not recruiting
First Posted : December 28, 2007
Last Update Posted : January 4, 2018
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

Brief Summary:
The purpose of this study is to learn how often lung cancer survivors exercise. We also want to learn what helps people to be active or prevents them from being active. Learning this will help us to expand services for lung cancer survivors.

Condition or disease
Lung Cancer Survivors

Detailed Description:
Despite the potential benefits of physical activity, particularly for cancer survivors with comorbid pulmonary and cardiac conditions, no previous research has examined the physical activity levels of lung cancer survivors, an underrepresented subpopulation in cancer survivorship research. We address this research gap in the current study, in which a random sample of 200 lung cancer survivors will complete a comprehensive telephone interview or use self-report to complete a questionnaire focusing on physical activity, related covariates, and preferences regarding physical activity counseling and interventions. We estimate the total time for the completion of the interview or self-report questionnaire to be 45-60 minutes. This study will be conducted with survivors of primary lung cancer who are from 1 to 5 years posttreatment and were treated at Memorial Sloan-Kettering Cancer Center (MSKCC).

Study Type : Observational
Actual Enrollment : 188 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Physical Activity and Inactivity in Lung Cancer Survivors
Study Start Date : September 2005
Estimated Primary Completion Date : September 2018
Estimated Study Completion Date : September 2018

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Primary Outcome Measures :
  1. The primary outcomes of this study are physical activity levels and preferences regarding physical activity counseling and interventions [ Time Frame: 45-60 minutes ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Eligible lung cancer survivors will be identified by the Thoracic DMT Data Manager from the Thoracic Surgical Database.

Inclusion Criteria:

  • Diagnosis of primary Stage IA or IB NSCLC;
  • Underwent surgical resection for NSCLC at MSKCC;
  • From 1 to 5 years post-treatment for NSCLC prior to study recruitment;
  • No evidence of disease (NED) at the time of recruitment;
  • Can be reached by telephone;
  • Able to provide informed consent.

Exclusion Criteria:

  • Undergoing active antineoplastic treatment;
  • Major psychopathology or cognitive impairment likely in the judgment of the investigator to interfere with participation and compliance with the protocol.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00582348

United States, New York
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065
Sponsors and Collaborators
Memorial Sloan Kettering Cancer Center
National Institutes of Health (NIH)
Principal Investigator: Jamie Ostroff, PhD Memorial Sloan Kettering Cancer Center

Additional Information:
Responsible Party: Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT00582348     History of Changes
Other Study ID Numbers: 05-094
Grant # CA115212
First Posted: December 28, 2007    Key Record Dates
Last Update Posted: January 4, 2018
Last Verified: January 2018

Keywords provided by Memorial Sloan Kettering Cancer Center:
Lung Cancer

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lung Diseases
Respiratory Tract Diseases